Results 71 to 80 of about 149,105 (224)

Factors related to longitudinal adherence in colorectal cancer screening:qualitative research findings [PDF]

, 2018
Background: The effectiveness of screening in colorectal cancer prevention depends on sustained participation rates. The objective of this study was to explore factors related to the longitudinal adherence of screening behavior in the context of a ...
A Calazel-Benque, A Kapidzic, A Maxwell, A Wools, Albert Farre, Angels Cardona, AS O’Malley, B Denis, BG Glaser, C Beeker, C Khalid-de Bakker, C Vrinten, Carmen Vidal, CK Palmer, Commission of the European Communities (CEC), DM Parkin, DP Weller, G Grazzini, G Marshall, Gemma Binefa, GN Honein-AbouHaidar, H Brenner, H Brenner, J Ferlay, J Tinmouth, JD Hardcastle, JL Bulliard, JS Mandel, K Leuraud, L Clemow, L Hol, L Jandorf, LA Peipins, LG Rossum van, Llucia Benito, M Bridou, M Euler-Chelpin von, M García, M Orton, M Peris, M Vlugt van der, Margarita Pla, MM Amonkar, Montse García, MQ Patton, N Mays, N Milà, N Segnan, O Krönborg, P Hewitson, R Nishihara, RE Myers, RE Schoen, RJ Steele, RK Wong, RM Jones, S Crotta, SH Lo, SH Lo, SJ Winawer, V Braun, V Goel, WS Atkin, ZF Gellad   +63 more
core   +3 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Colorectal Cancer Screening: A Guide to the Guidelines

Canadian Journal of Gastroenterology, 1999
The two most recent guidelines for colorectal cancer screening are those of the Agency for Healthcare Policy and Research, and the American Cancer Society.
Douglas K Rex
doaj   +1 more source

An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial. [PDF]

, 2019
BackgroundColorectal cancer is the fourth most commonly diagnosed cancer in the United States. Approximately 3-10% of the population has an increased risk for colorectal cancer due to family history and warrants more frequent or intensive screening. Yet,
Coffman, Cynthia J, Datta, Santanu K, Fisher, Deborah A, Goldstein, Karen M, Grubber, Janet M, Hauser, Elizabeth R, Nelson, Richard E, Orlando, Lori A, Provenzale, Dawn, Rakhra-Burris, Tejinder, Scheuner, Maren T, Sperber, Nina, Strawbridge, Elizabeth, Voils, Corrine I, Wang, Virginia, Wu, R Ryanne   +15 more
core  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Patient Understanding of Benefits, Risks, and Alternatives to Screening Colonoscopy [PDF]

, 2013
While several tests and strategies are recommended for colorectal cancer (CRC) screening, studies suggest that primary care providers often recommend colonoscopy without providing information about its risks or alternatives.
Barrett, Patrick R., Edenberg, Elizabeth, Imperiale, Thomas F., Meslin, Eric M., Perkins, Susan M., Schwartz, Peter H.   +5 more
core   +1 more source

Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer. [PDF]

, 2020
Background: Quantitative faecal immunochemical tests measure faecal haemoglobin concentration (f-Hb), which increases in the presence of colorectal neoplasia.Objective: We examined the diagnostic accuracy of faecal immunochemical test (FIT)in patients at
Cleary, Shirley, Datt, Pooja, Digby, Jayne, Fraser, Callum G., Goudie, David R., Gray, Lynne, Humphries, Adam, Mowat, Craig, Steele, Robert J. C., Strachan, Judith A.   +9 more
core   +2 more sources

Colorectal cancer screening behaviors

PeerJ, 2021
Introduction Colorectal cancer screening program compliance in Turkey is around 20–30%. Factors that may affect preventive health behavior, mainly individuals’ values, beliefs and attitudes, should be explored. A “Health Belief Model” (HBM) scale was developed in 1950 to explain the insufficient participation of
Selda Tekiner, Gülsen Ceyhun Peker, Mine Ceylan Doğan   +2 more
openaire   +3 more sources

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea

BMC Cancer, 2017
Background Lung cancer survivors are more likely to develop colorectal and stomach cancer than the general population. However, little is known about the current status of gastrointestinal cancer screening practices and related factors among lung cancer ...
Sang Min Park, Jongmog Lee, Young Ae Kim, Yoon Jung Chang, Moon Soo Kim, Young Mog Shim, Jae Ill Zo, Young Ho Yun   +7 more
doaj   +1 more source